Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of Actinic Keratosis on the Face in Solid Organ Transplant Recipients
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2018
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions
- 17 Jul 2018 Status changed from recruiting to completed.
- 11 Apr 2018 Planned End Date changed from 1 Jan 2019 to 1 Jun 2019.
- 11 Apr 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Dec 2018.